WVE — Wave Life Sciences Share News
0.000.00%
Last trade - 00:00- $660.71m
- $170.11m
- $42.73m
U.S. STOCKS ON THE MOVE-Regeneron, HP Inc, Honeywell International
U.S. STOCKS ON THE MOVE-Cassava Sciences, Wave Life Sciences, Bumble
U.S. STOCKS ON THE MOVE-Bumble, Cassava Sciences, IonQ
Wave Life Sciences rises; JP Morgan resumes coverage with 'overweight'
Wave Life Sciences shares drop after larger-than-targeted equity raise
U.S. STOCKS ON THE MOVE-Crocs, First Solar, Qualcomm
U.S. STOCKS ON THE MOVE-ASML Holding, Meta, Crocs
Wave Life prices upsized $200 mln equity offering, shares edge higher
Brief: Wave Life Sciences Says Pricing Of Its Underwritten Public Offering Of 23.12 Mln At $8.00 Per Ordinary Share
U.S. STOCKS ON THE MOVE-SLM Corp, Amgen Inc, Cintas Corp
Wave Life continues surge after DMD drug data impresses
Brief: Wave Life Sciences Says It Reduced Maximum Offering Amount To $0 & No Longer Intends To Sell Ordinary Shares Under Prospectus
Brief: Wave Life Sciences Announces Proposed Public Offering Of Ordinary Shares And Pre-Funded Warrants
Brief: Wave Life Sciences Announces Positive Interim Data From Forward-53 Clinical Trial Evaluating Wve-N531 In Boys With Duchenne Muscular Dystrophy Amenable To Exon 53 Skipping
U.S. STOCKS ON THE MOVE-Revance, B Riley, Neuronetics
Wave Life Sciences up on FDA's rare pediatric disease tag for muscular disorder therapy
Brief: Wave Life Sciences Receives FDA Rare Pediatric Disease Designation For Wve-N531
Wave Life Sciences Ltd Reports Results For The Quarter Ended In June: Earnings Summary
Wave Life Sciences Ltd Expected To Post A Loss Of 21 Cents A Share: Earnings Preview